TipRanks
Go Ultimate55% OFF

Daniel A. Camardo Insider Profile

18 Followers

Daniel A. Camardo, Director at Cue Biopharma, holds 21.80K shares in Cue Biopharma (Ticker: CUE), holds 285.34K shares in Athersys (Ticker: ATHXQ), holds 51.18K shares in Horizon Therapeutics (Ticker: HZNP).

Daniel A. Camardo's Trading History

CUE
Cue Biopharma
Jul 10, 2026DirectorUninformative Buy―$454.97K
ATHXQ
Athersys
Oct 06, 2023CEO, DirectorUninformative Sell8.80K―
HZNP
Horizon Therapeutics
Mar 31, 2021―Uninformative Sell1.10M$5.95M

You May Also Like

Daniel A. Camardo insider profile FAQ

What is the percentage of profitable transactions made by Daniel A. Camardo?
The percentage of profitable transactions made by Daniel A. Camardo is 0%.
What is the average return per transaction made by Daniel A. Camardo?
The average return per transaction made by Daniel A. Camardo is -70.10%.
What stocks does Daniel A. Camardo hold?
Daniel A. Camardo holds: CUE, ATHXQ, HZNP stocks.
What was Daniel A. Camardo's most profitable transaction?
Daniel A. Camardo’s most profitable transaction was an Informative Sell of HZNP stock on November 6, 2020. The return on the trade was -46.60%.
What is Daniel A. Camardo's role in Cue Biopharma?
Daniel A. Camardo's role in Cue Biopharma is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.